中基健康(000972) - 2017 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was ¥191,611,687.47, representing a year-on-year increase of 38.44%[8] - Net profit attributable to shareholders of the listed company was ¥119,969,759.43, with a year-to-date increase of 17.95% to ¥367,582,592.19[8] - Basic earnings per share for the reporting period was ¥0.1556, compared to ¥0.1036 in the same period last year[8] - Net profit attributable to shareholders of the parent company reached ¥79,901,514.06, a 187.56% increase due to profitability this year[16] Assets and Liabilities - Total assets at the end of the reporting period reached ¥2,453,934,892.32, an increase of 1.71% compared to the previous year[8] - Net assets attributable to shareholders of the listed company increased by 9.76% to ¥913,058,348.44[8] - Cash and cash equivalents decreased by 40.26% to ¥133,235,643.14 due to various payments made during the period[16] - Deferred income tax liabilities increased by 71.05% to ¥1,052,819.18, resulting from changes in the value of available-for-sale financial assets[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 51,738[11] - The top shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., held 15.46% of shares[11] Operational Activities - The company reported a net cash flow from operating activities of -¥94,598,104.02 year-to-date[8] - Prepayments increased by 118.15% to ¥33,961,142.50, primarily for purchasing packaging materials during production[16] - Inventory rose by 39.38% to ¥893,820,284.49, attributed to the addition of new products[16] - Operating income from non-operating activities surged by 3,698.35% to ¥225,654,969.31, driven by increased debt waiver income[16] Financial Changes - Non-recurring gains and losses totaled ¥223,973,808.95, primarily from debt restructuring gains of ¥224,463,455.92[9] - The company reported a 676.74% increase in business tax and additional fees, totaling ¥4,725,829.24, due to changes in accounting[16] - Financial expenses rose by 47.84% to ¥28,444,190.63, mainly due to exchange rate fluctuations[16] - The company received cash from investments amounting to ¥1,024,180.57, marking a 100% increase as this business did not occur in the previous year[16] Commitments and Matters - The company has no significant matters or commitments that were not fulfilled during the reporting period[17][18]